Coupang, Inc. (CPNG)

G1 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	50,444	39,539	28,944	26,041	51,457	-
Market Cap Growth	45.22%	36.60%	11.15%	-49.39%	-	-
Enterprise Value	48,227	37,826	26,839	25,282	49,616	-
Last Close Price	27.67	21.98	16.19	14.71	29.38	-
PE Ratio	140.36	256.75	21.28	-	-	-
Forward PE	65.35	54.85	41.73	62.15	-	-
PS Ratio	1.55	1.31	1.19	1.26	2.80	-
PB Ratio	10.74	9.47	7.05	10.79	23.65	-
P/TBV Ratio	11.27	10.32	7.14	10.79	23.65	-
P/FCF Ratio	64.92	39.26	16.48	-	-	-
P/OCF Ratio	26.42	20.96	10.91	46.09	-	-
EV/Sales Ratio	1.49	1.25	1.10	1.23	2.70	-
EV/EBITDA Ratio	37.71	37.98	35.88	212.45	-	-
EV/EBIT Ratio	60.36	67.19	56.74	-	-	-
EV/FCF Ratio	62.07	37.56	15.28	-	-	-
Debt / Equity Ratio	0.98	0.89	0.68	1.00	0.98	-3.70
Debt / EBITDA Ratio	2.29	2.27	2.23	4.22	-	-
Debt / FCF Ratio	5.89	3.70	1.59	-	-	-
Asset Turnover	1.95	2.11	2.13	2.27	2.69	2.89
Inventory Turnover	10.58	11.39	10.95	10.31	11.85	11.13
Quick Ratio	0.78	0.82	0.80	0.73	0.77	0.36
Current Ratio	1.09	1.17	1.14	1.15	1.19	0.76
Return on Equity (ROE)	7.88%	1.59%	41.73%	-4.01%	-196.22%	-
Return on Assets (ROA)	3.02%	2.45%	2.59%	-0.77%	-10.92%	-7.77%
Return on Capital (ROIC)	5.90%	4.76%	5.05%	-1.54%	-25.26%	-22.69%
Return on Capital Employed (ROCE)	9.40%	7.40%	7.40%	-	-	-
Earnings Yield	0.72%	0.39%	4.70%	-0.35%	-3.00%	-
FCF Yield	1.54%	2.55%	6.07%	-1.00%	-2.11%	-
Buyback Yield / Dilution	-3.00%	-1.28%	-2.15%	-23.95%	-4808.31%	-49.06%

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q